News Conference News TVT 2023 No-Implant Shunt for HF Looks Safe, Feasible in Early Snapshot Michael O'Riordan June 12, 2023
News Conference News TVT 2023 ‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients Michael O'Riordan June 09, 2023
Presentation TVT 2023 Severe Tricuspid Regurgitation with prior tricuspid ring, valve in ring followed by valve in valve and subsequent deployment of vascular plugs Presenter: Muhammad Zulqarnain June 09, 2023
News Features TVT 2022 Minorities, Poorer Patients Missing Out on Structural Heart Care Michael O'Riordan June 15, 2022
News Conference News TVT 2021 Optimizing Medical Therapy Before Clip Repair for MR? ‘This Is Hard’ Todd Neale July 27, 2021
News Conference News TVT 2020 Real-world, Low-risk Patients Fare Well With Self-Expanding Evolut PRO Shelley Wood June 24, 2020
News Conference News TVT 2019 Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR Michael O'Riordan June 19, 2019
News Conference News TVT 2019 Transcarotid Bests Aortic/Apical for Alternative TAVR Access: TVT Registry Shelley Wood June 17, 2019
News Conference News TVT 2019 Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate Shelley Wood June 13, 2019
News Conference News TVT 2017 Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial Shelley Wood June 16, 2017
News Conference News TVT 2017 Volume Underload? More TAVRs Done, the Better the Operator Outcomes, Yet Many Patients Go Untreated Michael O'Riordan June 16, 2017
News Conference News TVT 2017 Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10 Shelley Wood June 12, 2017
News Conference News TVT 2016 What TAVR Needs Next . . . and What It’s Getting Shelley Wood June 17, 2016
News Conference News TVT 2016 To Intervene or Not to Intervene When the TAVR Patient Has CAD: New Insights Shelley Wood June 17, 2016
News Conference News TVT 2016 Minimalist Transfemoral TAVR Reduces Costs Without Adversely Affecting Clinical Outcomes Michael O'Riordan June 16, 2016